P/E Ratio (TTM)
-12.88
Mesoblast Limited currently has a P/E ratio of -12.88. The P/E ratio is a primary valuation multiple used to determine if a stock is overvalued or undervalued relative to its earnings.
Quarterly P/E
| Quarter | P/E Ratio |
|---|---|
| 2012-06-30 | — |
| 2012-09-30 | -60.98 |
| 2012-12-31 | -48.14 |
| 2013-03-31 | -45.61 |
| 2013-06-30 | -39.95 |
| 2013-09-30 | -57.08 |
| 2013-12-31 | -40.27 |
| 2014-03-31 | -27.23 |
| 2014-06-30 | -22.93 |
| 2014-09-30 | -30.63 |
| 2014-12-31 | -16.21 |
| 2015-03-31 | -15.67 |
| 2015-06-30 | -6.81 |
| 2015-09-30 | -21.28 |
| 2015-12-31 | -7.63 |
| 2016-03-31 | -14.65 |
| 2016-06-30 | 2.09 |
| 2016-09-30 | -5.46 |
| 2016-12-31 | -6.47 |
| 2017-03-31 | -22.42 |
| 2017-06-30 | -7.41 |
| 2017-09-30 | -19.48 |
| 2017-12-31 | 10.64 |
| 2018-03-31 | -6.89 |
| 2018-06-30 | -6.69 |
| 2018-09-30 | -11.05 |
| 2018-12-31 | -4.23 |
| 2019-03-31 | -5.44 |
| 2019-06-30 | -6.10 |
| 2019-09-30 | -33.58 |
| 2019-12-31 | -7.56 |
| 2020-03-31 | -7.08 |
| 2020-06-30 | -8.76 |
| 2020-09-30 | -20.48 |
| 2020-12-31 | -9.36 |
| 2021-03-31 | -8.91 |
| 2021-06-30 | -9.66 |
| 2021-09-30 | -8.22 |
| 2021-12-31 | -6.08 |
| 2022-03-31 | -6.22 |
| 2022-06-30 | -3.02 |
| 2022-09-30 | -4.87 |
| 2022-12-31 | -4.23 |
| 2023-03-31 | -5.92 |
| 2023-06-30 | -6.45 |
| 2023-09-30 | -3.11 |
| 2023-12-31 | -2.72 |
| 2024-03-31 | -6.24 |
| 2024-06-30 | -6.74 |
| 2024-09-30 | -9.63 |
| 2024-12-31 | -22.84 |
| 2025-03-31 | -14.38 |
| 2025-06-30 | -12.83 |
| 2025-09-30 | — |
| 2025-12-31 | — |
Annual P/E
| Year | P/E Ratio |
|---|
* P/E ratios are calculated using trailing twelve-month (TTM) earnings. Extreme values may indicate earnings anomalies or cyclical volatility.